compound 55 [PMID: 29889526]   Click here for help

GtoPdb Ligand ID: 10016

Antimalarial Ligand
Compound class: Synthetic organic
Comment: Compound 55 is the drug-like lead discovered as a result of a SAR investigation and is a 2,8-Disubstituted-1,5-naphthyridine derivative of MMV024101 [2].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 107.21
Molecular weight 430.07
XLogP 3.15
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES FC(c1nccc(c1)c1ccnc2c1nc(cc2)c1cccc(c1)S(=O)(=O)N)(F)F
Isomeric SMILES FC(c1nccc(c1)c1ccnc2c1nc(cc2)c1cccc(c1)S(=O)(=O)N)(F)F
InChI InChI=1S/C20H13F3N4O2S/c21-20(22,23)18-11-12(6-8-26-18)15-7-9-25-17-5-4-16(27-19(15)17)13-2-1-3-14(10-13)30(24,28)29/h1-11H,(H2,24,28,29)
Guide to Malaria Pharmacology Comments
Compound 55 is the lead representative of a novel chemotype with potent antimalarial activity against both chloroquine sensitive and multidrug resistant Plasmodium strains [2].

Potential Target/Mechanism Of Action: Compound 55 is an inhibitor of P. falciparum phosphatidylinositol-4-kinase (PfPI4K) [2].